Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS‐CoV‐2 vaccination in kidney transplant recipients-Reference-Cited by-同舟云学术

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS‐CoV‐2 vaccination in kidney transplant recipients

Published:2021-11 Issue:2 Volume:22 Page:634-639
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American J Transplantation

Author:

Kantauskaite Marta¹,Müller Lisa²,Kolb Thilo¹³,Fischer Svenja¹,Hillebrandt Jonas¹,Ivens Katrin¹³,Andree Marcel²,Luedde Tom⁴,Orth Hans M.⁴,Adams Ortwin²,Schaal Heiner²,Schmidt Claudia¹,Königshausen Eva¹³,Rump Lars C.¹³,Timm Jörg²,Stegbauer Johannes¹³^ORCID

Affiliation:

1. Department of Nephrology Medical Faculty University Hospital Düsseldorf Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany

2. Institute of Virology Medical Faculty University Hospital Düsseldorf Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany

3. KfH Kuratorium für Dialyse und Nierentransplantation e.V Düsseldorf Germany

4. Department of Gastroenterology, Hepatology and Infectious diseases Medical Faculty University Hospital Düsseldorf Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany

Funder

Heinrich-Heine-Universität Düsseldorf

Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16851

Reference22 articles.

1. COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes